Phenylketonuria (PKU) Clinical Trial
Official title:
A Phase 1/2 Open-Label, Dose Escalation Study to Determine the Safety and Efficacy of BMN 307, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Phenylalanine Hydroxylase in Subjects With Phenylketonuria
This is a Phase 1/2, open-label, dose escalation study to evaluate the safety, efficacy and tolerability of BMN 307 in adult PKU subjects with PAH deficiency. Participants will receive a single administration of BMN 307 and will be followed for safety and efficacy.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03694353 -
Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
|
Phase 3 | |
| Completed |
NCT04086511 -
PANDA: PKU Amino Acid Evaluation
|
||
| Completed |
NCT02440932 -
Impact of Phenylketonuria-type Diet on Appetite, Appetite Hormones and Diet Induced Thermogenesis
|
N/A | |
| Completed |
NCT01617070 -
Effects of Kuvan on Melatonin Secretion
|
Phase 4 | |
| Completed |
NCT03505125 -
A Non-Interventional Interview Study of Phenylketonuria (PKU) Adults
|
||
| Terminated |
NCT01806051 -
A Pilot Study on Diurnal Variation
|
N/A | |
| Recruiting |
NCT05813678 -
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
|
||
| Active, not recruiting |
NCT05270837 -
Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria
|
Phase 3 | |
| Completed |
NCT01889862 -
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
|
Phase 3 | |
| Completed |
NCT02009904 -
Simple Breath Test to Examine Phenylalanine Metabolism
|
||
| Recruiting |
NCT06305234 -
A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
|
||
| Recruiting |
NCT03309345 -
Body Composition, Energy Intake and Expenditure in People With Phenylketonuria
|
N/A |